Search
Lexanersen
go.drugbank.com/drugs/DB17933InvestigationalLexanersen is an antisense oligonucleotide under investigation for use as a disease-modifying therapy in Huntington's disease.
RTL-1000
go.drugbank.com/drugs/DB17946InvestigationalRTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
PARPI F-18
go.drugbank.com/drugs/DB18657ExperimentalPARPI F-18 is a diagnostic agent under investigation for use in the management of glioblastoma multiforme.
Canvuparatide
go.drugbank.com/drugs/DB18658InvestigationalCanvuparatide is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of hyperparathyroidism.[L48365]
Ivonescimab
go.drugbank.com/drugs/DB18931InvestigationalIvonescimab is under investigation in clinical trial NCT05184712 (Phase 3 Clinical Study of AK112 for NSCLC Patients).
Lactide, L-
go.drugbank.com/drugs/DB19115InvestigationalLactide, L- is under investigation in clinical trial NCT05450471 (Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis).
KB109
go.drugbank.com/drugs/DB16531ExperimentalKB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.
Hydrogen
go.drugbank.com/drugs/DB15127InvestigationalHydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).
Asunercept
go.drugbank.com/drugs/DB15160InvestigationalAsunercept is under investigation in clinical trial NCT02853565 (A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme).
PF-03654746
go.drugbank.com/drugs/DB12201InvestigationalPF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.